NovaBridge Biosciences NBP
- givastomig — Gastric Cancer Phase 2
- ragistomig — Solid Tumors Phase 1
- givastomig — Biliary Tract Cancer Phase 1
- givastomig — Pancreatic Cancer Phase 1
4-1BB (3 companies · 9 programs)
Companies with an active program directed at 4-1BB.
Compass Therapeutics, Inc. CMPX
- CTX-471 — Melanoma Phase 1
- CTX-471 — Small Cell Lung Cancer Phase 1
- CTX-471 — Mesothelioma Phase 1
Aptevo Therapeutics Inc. APVO
- ALG.APV-527 — Solid Tumors Phase 1
- APVO603 Preclinical